Search results
Sen. Hassan slams GlaxoSmithKline over cost of asthma inhalers
New Hampshire Union Leader· 2 days agoPharmaceutical giant GlaxoSmithKline is sidestepping its pledge to lower asthma inhaler prices, a...
Senator slams drugmaker for seeming to skirt pledge to cap inhaler cost
The Hill· 23 hours agoDrug manufacturing giant GlaxoSmithKline (GSK) is subverting its pledge to lower the price of its...
Competition from 'skinny label' generics saved medicare billions, according to report
Medical Xpress· 54 minutes agoAn analysis of 15 name-brand drugs and their "skinny label" generic counterparts found that...
GSK profit drops in first quarter on higher costs
Digital Journal· 2 days agoBritish drugmaker GlaxoSmithKline on Wednesday said its net profit fell 23 percent in the first quarter as the company faced higher exceptional costs...
5 best blue chip stocks to invest in for sustainable gains in May - excluding Apple Inc. (AAPL) |...
Invezz· 10 hours agoYesterday, the biggest company in the world in terms of market cap reported its latest earnings....
Two possible bird flu vaccines could be available within weeks, if needed
NBC News via Yahoo News· 2 days agoThe U.S. has two vaccines ready that could begin shipping widely within a few weeks if the H5N1 bird...
Most RA Patients Meet EMA's JAK Inhibitor Warning Criteria
Medscape· 14 hours agoRecent regulatory warnings could mean that four in five patients with RA may not be prescribed JAK...
Suddenly, Chinese Spies Seem to Be Popping Up All Over Europe
The New York Times via Yahoo News· 6 days agoOne of the men, a young Briton known for his hawkish views on China, worked as an aide to a...
US challenges ‘bogus’ patents on Ozempic and other drugs in effort to spur competition
KOLR - KSFX Ozarks· 3 days agoWASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration target…
FTC Warns ‘Junk Patents’ Could Make Drugs Like Ozempic Pricier—Here’s How
Forbes· 4 days agoThe FTC sent warning letters to 10 pharmaceutical companies—including Novo Nordisk, AstraZeneca, ...